-
Je něco špatně v tomto záznamu ?
Prevention of mast cell degranulation by disodium cromoglycate attenuates the development of hypoxic pulmonary hypertension in rats exposed to chronic hypoxia
A Banasova, H Maxova, V Hampl, M Vizek, V Povysilova, J Novotna, O Vajnerova, O Hnilickova, J Herget
Jazyk angličtina Země Švýcarsko
NLK
Karger Journals
od 1998-01-01 do 2009
ProQuest Central
od 1998-01-01 do Před 1 rokem
Medline Complete (EBSCOhost)
od 2005-01-01 do Před 1 rokem
Nursing & Allied Health Database (ProQuest)
od 1998-01-01 do 2015-12-31
Health & Medicine (ProQuest)
od 1998-01-01 do Před 1 rokem
PubMed
18349522
DOI
10.1159/000121410
Knihovny.cz E-zdroje
- MeSH
- arteria pulmonalis metabolismus MeSH
- degranulace buněk účinky léků MeSH
- financování organizované MeSH
- hypoxie komplikace MeSH
- kolagen metabolismus MeSH
- kromoglykát dvojsodný farmakologie MeSH
- krysa rodu rattus MeSH
- mastocyty fyziologie účinky léků MeSH
- plicní hypertenze etiologie metabolismus patofyziologie prevence a kontrola MeSH
- potkani Wistar MeSH
- zvířata MeSH
- Check Tag
- krysa rodu rattus MeSH
- mužské pohlaví MeSH
- zvířata MeSH
BACKGROUND: Chronic hypoxia induces lung vascular remodeling, which results in pulmonary hypertension. Vascular remodeling is associated with collagenolysis and activation of matrix metalloproteinases (MMPs). One of the possible sources of MMPs in hypoxic lung are mast cells. OBJECTIVE: The role of lung mast cell collagenolytic activity in hypoxic pulmonary hypertension was tested by the inhibitor of mast cell degranulation disodium cromoglycate (DSCG). METHODS: Rats were treated with DSCG in an early or later phase of isobaric hypoxia. Control groups were exposed to hypoxia only or to normoxia. Lung hemodynamics, muscularization and collagen metabolism in the walls of peripheral pulmonary vessels in the lungs were measured. RESULTS: DSCG applied at an early phase of exposure to hypoxia reduced the development of pulmonary hypertension, inhibited muscularization in peripheral pulmonary arteries and decreased the amount of collagen cleavage fragments in prealveolar vessels. CONCLUSIONS: Mast cell degranulation plays a role in the initiation of hypoxic pulmonary vascular remodeling. 2008 S. Karger AG, Basel.
Citace poskytuje Crossref.org
- 000
- 02107naa 2200481 a 4500
- 001
- bmc11004075
- 003
- CZ-PrNML
- 005
- 20121130130824.0
- 008
- 110303s2008 sz e eng||
- 009
- AR
- 024 __
- $a 10.1159/000121410 $2 doi
- 035 __
- $a (PubMed)18349522
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Baňasová, Alena, $d 1973- $7 xx0074189
- 245 10
- $a Prevention of mast cell degranulation by disodium cromoglycate attenuates the development of hypoxic pulmonary hypertension in rats exposed to chronic hypoxia / $c A Banasova, H Maxova, V Hampl, M Vizek, V Povysilova, J Novotna, O Vajnerova, O Hnilickova, J Herget
- 314 __
- $a Department of Physiology, Charles University Second Medical School Prague, Prague, Czech Republic.
- 520 9_
- $a BACKGROUND: Chronic hypoxia induces lung vascular remodeling, which results in pulmonary hypertension. Vascular remodeling is associated with collagenolysis and activation of matrix metalloproteinases (MMPs). One of the possible sources of MMPs in hypoxic lung are mast cells. OBJECTIVE: The role of lung mast cell collagenolytic activity in hypoxic pulmonary hypertension was tested by the inhibitor of mast cell degranulation disodium cromoglycate (DSCG). METHODS: Rats were treated with DSCG in an early or later phase of isobaric hypoxia. Control groups were exposed to hypoxia only or to normoxia. Lung hemodynamics, muscularization and collagen metabolism in the walls of peripheral pulmonary vessels in the lungs were measured. RESULTS: DSCG applied at an early phase of exposure to hypoxia reduced the development of pulmonary hypertension, inhibited muscularization in peripheral pulmonary arteries and decreased the amount of collagen cleavage fragments in prealveolar vessels. CONCLUSIONS: Mast cell degranulation plays a role in the initiation of hypoxic pulmonary vascular remodeling. 2008 S. Karger AG, Basel.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a hypoxie $x komplikace $7 D000860
- 650 _2
- $a degranulace buněk $x účinky léků $7 D015550
- 650 _2
- $a kolagen $x metabolismus $7 D003094
- 650 _2
- $a kromoglykát dvojsodný $x farmakologie $7 D004205
- 650 _2
- $a plicní hypertenze $x etiologie $x metabolismus $x patofyziologie $x prevence a kontrola $7 D006976
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a mastocyty $x fyziologie $x účinky léků $7 D008407
- 650 _2
- $a arteria pulmonalis $x metabolismus $7 D011651
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a potkani Wistar $7 D017208
- 650 _2
- $a financování organizované $7 D005381
- 700 1_
- $a Maxová, Hana, $d 1968- $7 xx0037102
- 700 1_
- $a Hampl, Václav, $d 1962- $7 nlk20030127352
- 700 1_
- $a Vízek, Martin, $d 1943- $7 jn20000402660
- 700 1_
- $a Povýšilová, Viera, $d 1943- $7 nlk20030132170
- 700 1_
- $a Novotná, Jana, $d 1954- $7 xx0072049
- 700 1_
- $a Vajnerová, Olga $7 xx0036859
- 700 1_
- $a Hniličková, Olga $7 xx0077558
- 700 1_
- $a Herget, Jan, $d 1945-2019 $7 nlk19990073223
- 773 0_
- $t Respiration $w MED00004102 $g Roč. 76, č. 1 (2008), s. 102-107
- 910 __
- $a ABA008 $b x $y 1
- 990 __
- $a 20110413123326 $b ABA008
- 991 __
- $a 20121130130853 $b ABA008
- 999 __
- $a ok $b bmc $g 831415 $s 696103
- BAS __
- $a 3
- BMC __
- $a 2008 $b 76 $c 1 $d 102-107 $m Respiration $n Respiration $x MED00004102
- LZP __
- $a 2011-3B/ipme